A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitis
J Dermatolog Treat
.
2021 Aug;32(5):503-506.
doi: 10.1080/09546634.2019.1682498.
Epub 2019 Nov 25.
Authors
Catherine M Ludwig
1
,
Jeffrey M Krase
2
,
Kyla N Price
1
,
Peter A Lio
3
4
,
Vivian Y Shi
2
Affiliations
1
University of Illinois Chicago College of Medicine, Chicago, IL, USA.
2
Department of Medicine, Division of Dermatology, University of Arizona, Tucson, AZ, USA.
3
Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
4
Medical Dermatology Associates of Chicago, Chicago, IL, USA.
PMID:
31619094
DOI:
10.1080/09546634.2019.1682498
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized
Dermatitis, Atopic* / drug therapy
Eczema*
Humans
Immunosuppressive Agents / therapeutic use
Substances
Antibodies, Monoclonal, Humanized
Immunosuppressive Agents
dupilumab